114 related articles for article (PubMed ID: 38926107)
1. Exosome-Mediated Transfer of ALDH2 in Nasopharyngeal Carcinoma Cells Confers Increased Resistance to Paclitaxel Treatment.
Yan J; Wu L; Zheng M; Pan F
Discov Med; 2024 Jun; 36(185):1210-1220. PubMed ID: 38926107
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
3. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
[TBL] [Abstract][Full Text] [Related]
4. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.
Chi HM; Du JD; Cheng J; Mao HD
Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069
[TBL] [Abstract][Full Text] [Related]
5. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
6. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
[TBL] [Abstract][Full Text] [Related]
7. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
8. CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis.
Wang BR; Han JB; Jiang Y; Xu S; Yang R; Kong YG; Tao ZZ; Hua QQ; Zou Y; Chen SM
Autophagy; 2024 Feb; 20(2):329-348. PubMed ID: 37776538
[TBL] [Abstract][Full Text] [Related]
9. The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.
Zhu Y; He D; Bo H; Liu Z; Xiao M; Xiang L; Zhou J; Liu Y; Liu X; Gong L; Ma Y; Zhou Y; Zhou M; Xiong W; Yang F; Xing X; Li R; Li W; Cao K
Oncogene; 2019 Aug; 38(32):6065-6081. PubMed ID: 31273338
[TBL] [Abstract][Full Text] [Related]
10. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
[TBL] [Abstract][Full Text] [Related]
11. The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.
Hou Y; Zhu Q; Li Z; Peng Y; Yu X; Yuan B; Liu Y; Liu Y; Yin L; Peng Y; Jiang Z; Li J; Xie B; Duan Y; Tan G; Gulina K; Gong Z; Sun L; Fan X; Li X
Cell Death Dis; 2017 Mar; 8(3):e2659. PubMed ID: 28277541
[TBL] [Abstract][Full Text] [Related]
12. Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.
Gao J; Shao Z; Yan M; Fu T; Zhang L; Yan Y
Cancer Biomark; 2018; 22(4):641-648. PubMed ID: 29914005
[TBL] [Abstract][Full Text] [Related]
13. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
14. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
15. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
16. RIG-I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma.
Jing D; Zhou W; Shen L; Zhang Q; Xie WT; Shen E; Li Z; Shen LF; Sun LQ
Cancer Med; 2019 Oct; 8(14):6344-6357. PubMed ID: 31464090
[TBL] [Abstract][Full Text] [Related]
17. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.
Shen Z; Zeng Y; Guo J; Wu Y; Jiang X; Ding R; Wu C; Li R; Luo B; Zeng C; Jiang H; Jie W
J Transl Med; 2013 Sep; 11():217. PubMed ID: 24047082
[TBL] [Abstract][Full Text] [Related]
19. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
20. Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma.
Liu L; Liu S; Deng P; Liang Y; Xiao R; Tang LQ; Chen J; Chen QY; Guan P; Yan SM; Huang X; Hong JH; Chen J; Sun Y; Teh BT; Yu Q; Mai HQ; Tan J
Cancer Res; 2021 Mar; 81(5):1413-1425. PubMed ID: 33402387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
